• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Pet Diabetes Care Market

    ID: MRFR/HC/41701-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Pet Diabetes Care Market Research Report By Product Type (Insulin, Oral Medications, Continuous Glucose Monitors, Diabetic Pet Food), By Animal Type (Dogs, Cats, Other Pets), By Distribution Channel (Veterinary Clinics, Online Stores, Pharmacies, Pet Specialty Stores), By Treatment Type (Insulin Treatment, Dietary Management, Monitoring Devices) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Pet Diabetes Care Market Infographic
    Purchase Options

    Pet Diabetes Care Market Summary

    As per MRFR analysis, the Pet Diabetes Care Market was estimated at 2.3 USD Billion in 2024. The Pet Diabetes Care industry is projected to grow from 2.444 USD Billion in 2025 to 4.49 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.27 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Pet Diabetes Care Market is experiencing robust growth driven by increasing awareness and technological advancements.

    • Rising awareness of pet health is significantly influencing the demand for diabetes care products in North America.
    • Technological advancements in treatment options are enhancing the effectiveness of diabetes management for pets, particularly in the Asia-Pacific region.
    • The pet humanization trend is leading to increased spending on diabetes care, with dogs representing the largest segment and cats showing the fastest growth.
    • The rising incidence of diabetes in pets and advancements in veterinary medicine are key drivers propelling market expansion.

    Market Size & Forecast

    2024 Market Size 2.3 (USD Billion)
    2035 Market Size 4.49 (USD Billion)
    CAGR (2025 - 2035) 6.27%

    Major Players

    Zoetis (US), Boehringer Ingelheim (DE), Merck Animal Health (US), Elanco Animal Health (US), Vetoquinol (FR), Ceva Santé Animale (FR), PetIQ (US), Virbac (FR)

    Pet Diabetes Care Market Trends

    The Pet Diabetes Care Market is currently experiencing a notable evolution, driven by an increasing awareness of pet health and the rising prevalence of diabetes among companion animals. Pet owners are becoming more informed about the condition, leading to a greater demand for specialized products and services. This market encompasses a variety of offerings, including insulin therapies, dietary solutions, and monitoring devices, all aimed at managing diabetes in pets effectively. As the understanding of pet diabetes deepens, stakeholders are likely to innovate and expand their product lines to cater to the diverse needs of pet owners. Moreover, the Pet Diabetes Care Market appears to be influenced by advancements in veterinary medicine and technology. Enhanced diagnostic tools and treatment options are emerging, which may improve the quality of life for diabetic pets. Additionally, the growing trend of pet humanization is prompting owners to seek out high-quality care solutions, further propelling market growth. As the landscape continues to shift, it is essential for businesses to remain agile and responsive to the evolving demands of pet owners, ensuring that they provide effective and reliable diabetes management solutions for their beloved animals.

    Rising Awareness of Pet Health

    There is a growing consciousness among pet owners regarding the health and well-being of their animals. This trend is leading to increased demand for diabetes management products and services, as owners seek to ensure their pets receive the best possible care.

    Technological Advancements in Treatment

    Innovations in veterinary medicine are paving the way for new diagnostic and treatment options. These advancements may enhance the management of diabetes in pets, offering more effective solutions for both pets and their owners.

    Pet Humanization Trend

    The trend of treating pets as family members is influencing purchasing decisions. Pet owners are increasingly inclined to invest in high-quality diabetes care products, reflecting their commitment to their pets' health and happiness.

    The rising prevalence of diabetes among pets underscores the urgent need for enhanced management solutions and educational resources for pet owners, reflecting a growing awareness of pet health and wellness.

    U.S. Food and Drug Administration (FDA)

    Pet Diabetes Care Market Drivers

    Growing Awareness of Pet Nutrition

    The heightened awareness surrounding pet nutrition is emerging as a significant driver in the Pet Diabetes Care Market. Pet owners are increasingly educated about the impact of diet on their pets' health, particularly concerning diabetes management. This awareness has led to a surge in demand for specialized diabetic pet foods that are formulated to regulate blood sugar levels. Market data suggests that sales of these specialized diets are on the rise, as owners seek to provide their pets with optimal nutrition. Additionally, veterinary professionals are emphasizing the importance of dietary management in diabetes care, further propelling the growth of the Pet Diabetes Care Market. As nutritional knowledge continues to evolve, the market is likely to expand, offering innovative solutions for managing pet diabetes.

    Advancements in Veterinary Medicine

    Technological innovations in veterinary medicine are significantly influencing the Pet Diabetes Care Market. The introduction of advanced diagnostic tools, such as continuous glucose monitors and insulin pumps, has revolutionized the management of diabetes in pets. These technologies not only enhance the accuracy of diabetes diagnosis but also improve the quality of life for affected animals. Furthermore, the development of specialized diets tailored for diabetic pets has gained traction, with market data indicating a rise in sales of prescription pet foods. As veterinary practices adopt these cutting-edge technologies, the Pet Diabetes Care Market is expected to experience substantial growth, driven by the demand for more effective and efficient treatment options.

    Increased Pet Ownership and Spending

    The rise in pet ownership and the corresponding increase in spending on pet care are pivotal factors driving the Pet Diabetes Care Market. Recent statistics reveal that pet ownership rates have surged, with millions of households welcoming pets into their lives. This trend is accompanied by a willingness among pet owners to invest in their pets' health, including diabetes management. The pet care market has seen a notable increase in expenditures, with owners prioritizing preventive care and specialized treatments. As more pet owners recognize the importance of managing diabetes effectively, the demand for products and services within the Pet Diabetes Care Market is likely to grow, reflecting a broader commitment to pet health and well-being.

    Rising Incidence of Diabetes in Pets

    The increasing prevalence of diabetes among pets is a primary driver of the Pet Diabetes Care Market. Recent studies indicate that diabetes cases in dogs and cats have risen significantly, with estimates suggesting that approximately 1 in 300 dogs and 1 in 200 cats are diagnosed with diabetes. This alarming trend necessitates the development of specialized care products and services, thereby expanding the market. As pet owners become more aware of the health risks associated with diabetes, they are more likely to seek veterinary care and invest in diabetes management solutions. This growing demand for effective treatment options, including insulin therapies and dietary management, is likely to propel the Pet Diabetes Care Market forward, as stakeholders respond to the urgent need for comprehensive care solutions.

    Regulatory Support for Pet Health Products

    Regulatory frameworks supporting the development and approval of pet health products are playing a crucial role in the Pet Diabetes Care Market. Governments and regulatory bodies are increasingly recognizing the importance of pet health, leading to the establishment of guidelines that facilitate the introduction of new diabetes care products. This supportive environment encourages innovation and investment in the development of effective treatments and management solutions for diabetic pets. As a result, companies are more inclined to invest in research and development, knowing that their products will have a clear pathway to market. This regulatory support is likely to enhance the Pet Diabetes Care Market, fostering a landscape where new and effective solutions can be introduced to meet the growing needs of pet owners.

    Market Segment Insights

    By Product Type: Insulin (Largest) vs. Continuous Glucose Monitors (Fastest-Growing)

    In the Pet Diabetes Care Market, the primary segment is Insulin, which holds the largest market share due to its established usage among diabetic pets. Insulin treatments remain essential for managing blood sugar levels in pets with diabetes, cementing their role as a staple in diabetic care. Conversely, Continuous Glucose Monitors are rapidly gaining traction, catering to the increasing demand for innovative and user-friendly health monitoring solutions. Their growth is notable as pet owners seek more versatile management tools for diabetes treatment. The demand for Oral Medications and Diabetic Pet Food is also significant, but they play a more supportive role compared to Insulin and Continuous Glucose Monitors. As pet owners become more educated about diabetes management, there is an upward trend in the adoption of these emerging solutions. The rise in pet ownership and the humanization of pets further drive the market, prompting companies to innovate and invest in developing advanced diabetic care products for pets.

    Insulin (Dominant) vs. Oral Medications (Emerging)

    Insulin is the dominant product type in the Pet Diabetes Care Market, integral to the management of diabetic pets' health. Its longstanding presence ensures trust and reliability among pet owners and veterinarians. Insulin provides essential glucoregulatory support, making it a critical component in diabetes care. In contrast, Oral Medications represent an emerging avenue for diabetes management, appealing to pet owners looking for alternatives to injections. These medications offer convenience and ease of use, contributing to improved adherence among pet owners. As a result, the market for oral solutions is expanding, driven by technological advancements and increased awareness of pet health, ultimately complementing the established dominance of Insulin.

    By Animal Type: Dogs (Largest) vs. Cats (Fastest-Growing)

    In the Pet Diabetes Care Market, the distribution of market share reveals that dogs represent the largest segment, driving significant demand for specialized diabetes care products. This dominance is attributed to the high prevalence of diabetes in dogs, leading to a robust market presence for related treatments and dietary products. Meanwhile, the cat segment is rapidly gaining traction, contributing to increasing sales as more pet owners recognize diabetes in their feline companions and seek appropriate care solutions.

    Dogs (Dominant) vs. Cats (Emerging)

    The dominance of the dog segment in the Pet Diabetes Care Market is primarily due to the established awareness of diabetes management among dog owners and the availability of tailored care products. With a variety of prescription diets, insulin injections, and glucose monitoring devices specifically designed for canines, this segment has seen consistent demand. In contrast, the cat segment is emerging as a significant player as awareness of feline diabetes increases. Owners are becoming more informed about specific dietary needs and treatment options, leading to a gradual, yet noticeable shift in the market dynamics as they seek better health solutions for their cats.

    By Distribution Channel: Veterinary Clinics (Largest) vs. Online Stores (Fastest-Growing)

    In the Pet Diabetes Care Market, Veterinary Clinics hold the largest share among the distribution channels. Their strong influence is primarily due to the trust pet owners place in these clinics for specialized care and advice regarding their pets' health. Online Stores also exhibit a notable market presence, catering to the growing demand for convenient purchasing options. This segment has seen a rise in pet owners seeking to buy diabetes care products with minimal hassle, highlighting an increasing trend toward e-commerce.

    Veterinary Clinics (Dominant) vs. Online Stores (Emerging)

    Veterinary Clinics are dominating the Pet Diabetes Care Market due to their established reputation and direct access to veterinarians who can recommend appropriate diabetes management products. This channel offers a personalized experience, where pet owners can receive hand-on product explanations and trusted guidance. On the other hand, Online Stores have emerged as a growing force, particularly in response to the digital shift in consumer behavior. They provide extensive product options and ease of access, attracting a younger, tech-savvy demographic looking for quick and convenient solutions for their pets’ health needs. The contrast between these segments illustrates a dynamic market landscape where traditional and modern retail channels co-exist.

    By Treatment Type: Insulin Treatment (Largest) vs. Dietary Management (Fastest-Growing)

    In the Pet Diabetes Care Market, Insulin Treatment currently holds the largest market share, significantly outpacing its counterparts - Dietary Management and Monitoring Devices. While Insulin is an essential component for managing diabetes in pets, the distribution of market shares reflects the increasing importance of holistic approaches in healthcare. Dietary Management is experiencing a swift rise as pet owners become more aware of the impact of diet on their pets' health outcomes, carving out a substantial niche within the market, alongside Insulin Treatment. Looking at growth trends, the Treatment Type segment is evolving rapidly with a notable shift towards more integrated management solutions for diabetic pets. The rise of Dietary Management as the fastest-growing segment indicates a trend where pet owners are prioritizing preventative care and nutritional strategies. Furthermore, advancements in Monitoring Devices are improving tracking for both pet owners and veterinarians, allowing for more informed decisions regarding treatment plans, which boosts overall confidence in managing diabetes effectively.

    Dietary Management (Dominant) vs. Monitoring Devices (Emerging)

    In the realm of Pet Diabetes Care, Dietary Management has emerged as a dominant treatment option among pet owners, emphasizing the importance of tailored nutrition for managing diabetes in pets. This approach not only aids in blood sugar stabilization but plays a pivotal role in prevention and overall health improvement. Numerous brands are capitalizing on this trend by offering specialized diets enriched with necessary nutrients that cater to diabetic pets, thus fostering a competitive edge in the market. On the other hand, Monitoring Devices are considered an emerging segment, gaining traction due to technological advancements. These devices provide real-time monitoring capabilities, essential for tracking the efficacy of treatments like dietary management and insulin administration, promoting proactive management of pet diabetes.

    Get more detailed insights about Pet Diabetes Care Market

    Regional Insights

    The Global Pet Diabetes Care Market shows notable growth across various regions, with the overall market set to reach a valuation of 2.3 USD Billion by 2024. North America dominates the landscape, holding a significant share of 1.1 USD Billion, expected to expand to 2.1 USD Billion by 2035. This robust market presence is fueled by increasing pet ownership and rising awareness of diabetes in pets.

    Europe follows, valued at 0.7 USD Billion in 2024, presenting a substantial market opportunity due to growing health concerns for pets and an inclination towards preventive care.The APAC region, while smaller, is growing steadily from 0.4 USD Billion to 0.8 USD Billion as pet owners become more informed about diabetes management. South America and MEA, each valued at just 0.05 USD Billion in 2024, represent niche markets with potential for growth as pet healthcare awareness increases.

    These regions collectively contribute to the Global Pet Diabetes Care Market revenue, showcasing varied growth of drivers and unique challenges that shape their trajectories in the pet diabetes care industry. The significance of these diverse regional dynamics is vital in understanding overall market growth and segmentation.

    Pet Diabetes Care Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Pet Diabetes Care Market is witnessing significant growth due to the rising prevalence of diabetes in pets, leading to an increased focus on innovative care solutions and products tailored specifically for this condition. As pet owners become more aware of diabetes management and treatment options, companies are intensifying their efforts to develop specialized diets, medications, and monitoring tools to cater to this demand.

    The competitive landscape of this market is characterized by an array of players ranging from established brands to emerging startups, all striving to enhance their product offerings through research and development, strategic alliances, and targeted marketing campaigns. 

    The emphasis on improving pet health and extending the lives of beloved companions is underscored by the growing willingness of pet owners to invest in quality care solutions.Nestle Purina PetCare has established a strong presence in the Global Pet Diabetes Care Market with its innovative approach to pet nutrition and health management. The company focuses on creating specialized diets that cater to the nutritional needs of diabetic pets, emphasizing low glycemic index ingredients that help manage blood sugar levels.

    Nestle Purina's commitment to research and development is a notable strength, enabling them to formulate products based on the latest scientific insights into pet health and diabetes care. Their robust distribution channels and brand reputation further bolster their presence in the market, making their products both accessible and trusted among pet owners. Through educational initiatives, Nestle Purina PetCare engages pet owners in understanding their pets' health, offering resources that support diabetes management at home and enhancing customer loyalty.

    Mars Petcare, alongside its extensive product portfolio, is a key player in the Global Pet Diabetes Care Market, leveraging its expertise in animal nutrition and healthcare. The company focuses on offering a range of diabetic-friendly pet food options designed to help manage the condition effectively. Mars Petcare's strengths lie in its investment in cutting-edge research, allowing the company to continuously innovate and adapt its product offerings to meet the changing needs of pets with diabetes. Their global reach, supported by strong marketing strategies, ensures that their products are available to a wide audience.

    Additionally, Mars Petcare's dedication to animal welfare reinforces their brand image, making them a preferred choice for pet owners seeking reliable solutions to manage diabetes in their furry companions.

    Key Companies in the Pet Diabetes Care Market market include

    Industry Developments

    • Q2 2024: Merck Animal Health Launches Vetsulin® VetPen® 2, the Next Generation Insulin Pen for Diabetic Pets Merck Animal Health announced the launch of Vetsulin® VetPen® 2, an updated insulin delivery device designed to improve the management of diabetes in dogs and cats. The new device offers enhanced dosing accuracy and user-friendly features for pet owners and veterinarians.
    • Q1 2024: Zoetis Introduces AlphaTrak 3, a Next-Generation Blood Glucose Monitoring System for Pets Zoetis launched AlphaTrak 3, a new blood glucose monitoring system specifically designed for diabetic dogs and cats, featuring improved accuracy and connectivity with a mobile app for real-time data sharing with veterinarians.
    • Q2 2024: PetMed Express Appoints New Chief Executive Officer PetMed Express, a leading pet pharmacy, announced the appointment of a new CEO to drive growth and innovation in pet health solutions, including diabetes care products.
    • Q1 2024: Boehringer Ingelheim Receives EMA Approval for ProZinc® Insulin for Use in Diabetic Dogs Boehringer Ingelheim announced that the European Medicines Agency (EMA) has approved ProZinc® (protamine zinc insulin) for the treatment of diabetes mellitus in dogs, expanding its use beyond cats in the European market.
    • Q2 2024: Elanco Animal Health Announces Strategic Partnership with Pet Diabetes App Developer Elanco Animal Health entered into a partnership with a digital health company to integrate diabetes management tools for pets, aiming to improve remote monitoring and treatment adherence for diabetic animals.
    • Q1 2024: Companion Medical Launches InPen® for Veterinary Use in Pet Diabetes Management Companion Medical introduced the InPen® smart insulin pen for veterinary use, providing pet owners and veterinarians with digital insulin dosing support for diabetic dogs and cats.
    • Q2 2024: PetDx Raises $50 Million in Series B Funding to Expand Veterinary Diagnostic Solutions PetDx secured $50 million in Series B funding to accelerate the development and commercialization of advanced diagnostic tools, including solutions for early detection and management of diabetes in pets.
    • Q1 2024: Abbott Launches FreeStyle Libre for Veterinary Use in Continuous Glucose Monitoring Abbott announced the launch of its FreeStyle Libre continuous glucose monitoring system for veterinary use, enabling real-time glucose tracking for diabetic dogs and cats.
    • Q2 2024: Vetoquinol Opens New Manufacturing Facility for Veterinary Diabetes Care Products Vetoquinol inaugurated a new manufacturing facility dedicated to producing diabetes care products for pets, aiming to meet growing demand in North America and Europe.
    • Q1 2024: Nestlé Purina PetCare Launches Specialized Diet for Diabetic Cats Nestlé Purina PetCare introduced a new veterinary diet formulated specifically for the nutritional management of diabetes in cats, available through veterinary clinics.
    • Q2 2024: Hill's Pet Nutrition Announces Launch of Prescription Diet m/d GlucoSupport for Diabetic Dogs Hill's Pet Nutrition launched Prescription Diet m/d GlucoSupport, a new therapeutic food designed to help manage blood glucose levels in diabetic dogs.
    • Q1 2024: Bayer Animal Health Partners with Veterinary Telemedicine Platform to Enhance Diabetes Care Bayer Animal Health formed a partnership with a leading veterinary telemedicine provider to offer remote diabetes management support for pet owners and veterinarians.

    Future Outlook

    Pet Diabetes Care Market Future Outlook

    The Pet Diabetes Care Market is projected to grow at a 6.27% CAGR from 2024 to 2035, driven by increasing pet ownership, rising awareness, and advancements in veterinary care.

    New opportunities lie in:

    • Development of telehealth platforms for remote diabetes management
    • Introduction of specialized diabetic pet food lines
    • Expansion of mobile veterinary clinics offering diabetes care services

    By 2035, the Pet Diabetes Care Market is expected to be robust, reflecting significant growth and innovation.

    Market Segmentation

    Pet Diabetes Care Market Animal Type Outlook

    • Dogs
    • Cats
    • Other Pets

    Pet Diabetes Care Market Product Type Outlook

    • Insulin
    • Oral Medications
    • Continuous Glucose Monitors
    • Diabetic Pet Food

    Pet Diabetes Care Market Treatment Type Outlook

    • Insulin Treatment
    • Dietary Management
    • Monitoring Devices

    Pet Diabetes Care Market Distribution Channel Outlook

    • Veterinary Clinics
    • Online Stores
    • Pharmacies
    • Pet Specialty Stores

    Report Scope

    MARKET SIZE 20242.3(USD Billion)
    MARKET SIZE 20252.444(USD Billion)
    MARKET SIZE 20354.49(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.27% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesIntegration of telehealth solutions for remote monitoring of diabetic pets enhances care accessibility in the Pet Diabetes Care Market.
    Key Market DynamicsRising consumer awareness drives demand for innovative pet diabetes management solutions and personalized care options.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the Global Pet Diabetes Care Market in 2024?

    The Global Pet Diabetes Care Market is expected to be valued at 2.3 USD Billion in 2024.

    What is the projected market size for the Global Pet Diabetes Care Market in 2035?

    The market is projected to reach 4.5 USD Billion by 2035.

    What is the expected CAGR for the Global Pet Diabetes Care Market from 2025 to 2035?

    The expected CAGR for the market from 2025 to 2035 is 6.27%.

    What region dominates the Global Pet Diabetes Care Market in 2024?

    In 2024, North America dominates the market with a value of 1.1 USD Billion.

    How much is the Global Pet Diabetes Care Market in Europe projected to be worth in 2035?

    The market in Europe is projected to be worth 1.4 USD Billion in 2035.

    What are the expected values of Insulin in the Global Pet Diabetes Care Market for 2024 and 2035?

    Insulin is expected to be valued at 0.9 USD Billion in 2024 and 1.8 USD Billion in 2035.

    Who are the key players in the Global Pet Diabetes Care Market?

    Major players include Nestle Purina PetCare, Mars Petcare, Idexx Laboratories, and Merck Animal Health.

    What is the expected value of Continuous Glucose Monitors in 2024?

    The expected value of Continuous Glucose Monitors in 2024 is 0.6 USD Billion.

    What challenges are anticipated for the Global Pet Diabetes Care Market going forward?

    Challenges include rising treatment costs and access to specialized veterinary care.

    How is the market expected to grow in the Asia-Pacific region by 2035?

    The Asia-Pacific region is expected to grow to 0.8 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions